과제정보
This study was supported by a 2-Year Research Grant of Pusan National University, Republic of Korea.
참고문헌
- Land WG. Chronic allograft dysfunction: a model disorder of innate immunity. Biomed J. 2013;36:209-228. https://doi.org/10.4103/2319-4170.117622
- Hreggvidsdottir HS, Ostberg T, Wahamaa H, Schierbeck H, Aveberger AC, Klevenvall L, Palmblad K, Ottosson L, Andersson U, Harris HE. The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation. J Leukoc Biol. 2009;86:655-662. https://doi.org/10.1189/jlb.0908548
- Kalinina N, Agrotis A, Antropova Y, DiVitto G, Kanellakis P, Kostolias G, Ilyinskaya O, Tararak E, Bobik A. Increased expression of the DNA-binding cytokine HMGB1 in human atherosclerotic lesions: role of activated macrophages and cytokines. Arterioscler Thromb Vasc Biol. 2004;24:2320-2325. https://doi.org/10.1161/01.ATV.0000145573.36113.8a
- Cai Y, Sukhova GK, Wong HK, Xu A, Tergaonkar V, Vanhoutte PM, Tang EH. Rap1 induces cytokine production in pro-inflammatory macrophages through NFκB signaling and is highly expressed in human atherosclerotic lesions. Cell Cycle. 2015;14:3580-3592. https://doi.org/10.1080/15384101.2015.1100771
- Zou H, Yang Y, Gao M, Zhang B, Ming B, Sun Y, Chen H, Tang X, Chen Z, Xiong P, Xu Y, Fang M, Tan Z, Gong F, Zheng F. HMGB1 is involved in chronic rejection of cardiac allograft via promoting inflammatory-like mDCs. Am J Transplant. 2014;14:1765-1777. https://doi.org/10.1111/ajt.12781
- Wang K, Li W, Yu Q, Guo B, Yang B, Zhang C, Li M, Li J, Hu S, Zheng Q, Song Z. High mobility group box 1 mediates interferon-γ-induced phenotypic modulation of vascular smooth muscle cells. J Cell Biochem. 2017;118:518-529. https://doi.org/10.1002/jcb.25682
- Porto A, Palumbo R, Pieroni M, Aprigliano G, Chiesa R, Sanvito F, Maseri A, Bianchi ME. Smooth muscle cells in human atheroscle-rotic plaques secrete and proliferate in response to high mobility group box 1 protein. FASEB J. 2006;20:2565-2566. https://doi.org/10.1096/fj.06-5867fje
- Kang R, Tang D, Schapiro NE, Loux T, Livesey KM, Billiar TR, Wang H, Van Houten B, Lotze MT, Zeh HJ. The HMGB1/RAGE inflammatory pathway promotes pancreatic tumor growth by regulating mitochondrial bioenergetics. Oncogene. 2014;33:567-577. https://doi.org/10.1038/onc.2012.631
- Andersson U, Tracey KJ. HMGB1 is a therapeutic target for sterile inflammation and infection. Annu Rev Immunol. 2011;29:139-162. https://doi.org/10.1146/annurev-immunol-030409-101323
- Jang EJ, Baek SE, Kim EJ, Park SY, Kim CD. HMGB1 enhances AGE-mediated VSMC proliferation via an increase in 5-LO-linked RAGE expression. Vascul Pharmacol. 2019;118-119:106559.
- Leclerc E, Fritz G, Vetter SW, Heizmann CW. Binding of S100 proteins to RAGE: an update. Biochim Biophys Acta. 2009;1793:993-1007. https://doi.org/10.1016/j.bbamcr.2008.11.016
- Yan SD, Chen X, Fu J, Chen M, Zhu H, Roher A, Slattery T, Zhao L, Nagashima M, Morser J, Migheli A, Nawroth P, Stern D, Schmidt AM. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature. 1996;382:685-691. https://doi.org/10.1038/382685a0
- Bierhaus A, Nawroth PP. Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications.Diabetologia. 2009;52:2251-2263. https://doi.org/10.1007/s00125-009-1458-9
- Newby AC. Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates. Cardiovasc Res. 2006;69:614-624. https://doi.org/10.1016/j.cardiores.2005.08.002
- Rakesh K, Agrawal DK. Cytokines and growth factors involved in apoptosis and proliferation of vascular smooth muscle cells. Int Immunopharmacol. 2005;5:1487-1506. https://doi.org/10.1016/j.intimp.2005.05.003
- Doran AC, Meller N, McNamara CA. Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arterioscler Thromb Vasc Biol. 2008;28:812-819. https://doi.org/10.1161/ATVBAHA.107.159327
- Dinarello CA. Biologic basis for interleukin-1 in disease. Blood. 1996;87:2095-2147. https://doi.org/10.1182/blood.V87.6.2095.bloodjournal8762095
- Schwencke C, Schmeisser A, Walter C, Wachter R, Pannach S, Weck B, Braun-Dullaeus RC, Kasper M, Strasser RH. Decreased caveolin-1 in atheroma: loss of antiproliferative control of vascular smooth muscle cells in atherosclerosis. Cardiovasc Res. 2005;68:128-135. https://doi.org/10.1016/j.cardiores.2005.05.004
- Chistiakov DA, Sobenin IA, Orekhov AN, Bobryshev YV. Human miR-221/222 in physiological and atherosclerotic vascular remodeling. Biomed Res Int. 2015;2015:354517.
- Burke AP, Kolodgie FD, Zieske A, Fowler DR, Weber DK, Varghese PJ, Farb A, Virmani R. Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem study. Arterioscler Thromb Vasc Biol. 2004;24:1266-1271. https://doi.org/10.1161/01.ATV.0000131783.74034.97
- Simard E, Sollradl T, Maltais JS, Boucher J, D'Orleans-Juste P, Grandbois M. Receptor for advanced glycation end-products signaling interferes with the vascular smooth muscle cell contractile phenotype and function. PLoS One. 2015;10:e0128881.
- Schmidt AM, Stern DM. RAGE: a new target for the prevention and treatment of the vascular and inflammatory complications of diabetes. Trends Endocrinol Metab. 2000;11:368-375. https://doi.org/10.1016/S1043-2760(00)00311-8
- Schmidt AM, Yan SD, Yan SF, Stern DM. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest. 2001;108:949-955. https://doi.org/10.1172/JCI200114002
- Umahara T, Uchihara T, Koyama S, Hashimoto T, Akimoto J, Haraoka J, Iwamoto T. Local extension of HMGB1 in atherosclerotic lesions of human main cerebral and carotid arteries. Histol Histopathol. 2014;29:235-242.
- Indolfi C, Torella D, Cavuto L, Davalli AM, Coppola C, Esposito G, Carriero MV, Rapacciuolo A, Di Lorenzo E, Stabile E, Perrino C, Chieffo A, Pardo F, Chiariello M. Effects of balloon injury on neointimal hyperplasia in streptozotocin-induced diabetes and in hyperinsulinemic nondiabetic pancreatic islet-transplanted rats. Circulation. 2001;103:2980-2986. https://doi.org/10.1161/01.CIR.103.24.2980
- Won SM, Park YH, Kim HJ, Park KM, Lee WJ. Catechins inhibit angiotensin II-induced vascular smooth muscle cell proliferation via mitogen-activated protein kinase pathway. Exp Mol Med. 2006;38:525-534. https://doi.org/10.1038/emm.2006.62
- Liang Y, Hou C, Kong J, Wen H, Zheng X, Wu L, Huang H, Chen Y. HMGB1 binding to receptor for advanced glycation end products enhances inflammatory responses of human bronchial epithelial cells by activating p38 MAPK and ERK1/2. Mol Cell Biochem. 2015;405:63-71. https://doi.org/10.1007/s11010-015-2396-0